Merck & Co., Inc.
- SEC CIK
- 0000310158
- Latest filing
- Aug 7, 2026
Holdings in Q2 2026
Holdings as of Jun 30, 2026, filed Aug 7, 2026. Long positions only; changes compare share counts with Q1 2026.
- Positions
- 13
- −1 vs. Q1 2026
- Portfolio value
- $526.4M
- +$177.0M (+50.6%) vs. Q1 2026
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PSNLPersonalis, Inc. | COM | 14,044,943 | $188.2M | 35.8% | 00.0% | Unchanged | History |
| MRNAModerna, Inc. | Stock | 2,308,190 | $161.6M | 30.7% | 00.0% | Unchanged | History |
| KYMRKymera Therapeutics, Inc. | COM | 772,165 | $88.5M | 16.8% | 00.0% | Unchanged | History |
| AKTSAktis Oncology, Inc. | COM | 952,844 | $30.7M | 5.8% | 00.0% | Unchanged | History |
| EIKNEikon Therapeutics, Inc. | COM | 1,666,666 | $21.7M | 4.1% | 00.0% | Unchanged | History |
| TRDAEntrada Therapeutics, Inc. | COM | 1,739,768 | $12.8M | 2.4% | +1,739,768 | New | History |
| STROSutro Biopharma, Inc. | COM SHS | 272,351 | $9.04M | 1.7% | +272,351 | New | History |
| ALECAlector, Inc. | COM | 3,545,719 | $7.13M | 1.4% | 00.0% | Unchanged | History |
| EVAXEvaxion A/S | ADR | 1,214,126 | $3.76M | 0.7% | +1,214,126 | New | History |
| VRDNViridian Therapeutics, Inc. | COM | 93,414 | $1.72M | 0.3% | 00.0% | Unchanged | History |
| XLOXilio Therapeutics, Inc. | COM | 105,982 | $1.02M | 0.2% | 00.0% | Unchanged | History |
| HURATuHURA Biosciences, Inc. | COM | 19,445 | $45.5K | <0.1% | 00.0% | Unchanged | History |
| NEUPNeuphoria Therapeutics Inc. | COM | 10,027 | $43.8K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q1 2026 (4)
Positions held at the end of Q1 2026 that are gone from this filing.
| Security | Class | Shares in Q1 2026 | Value in Q1 2026 | % of portfolio in Q1 2026 | History |
|---|---|---|---|---|---|
| Entrada Therapeutics Inc29384C908 | CALL | 1,739,768 | $22.0M | 6.3% | – |
| STROSutro Biopharma, Inc. | COM | 272,351 | $6.78M | 1.9% | History |
| EVAXEvaxion A/S | COM | 1,214,126 | $4.52M | 1.3% | History |
| CARMCarisma Therapeutics Inc. | COM | 1,473,240 | $47.9K | <0.1% | History |